<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="23" ids="18059">Lipid</z:chebi> kinase PIK3CA mutations have been described in several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>They clustered in two 'hot spots' located in helical (exon 9) and kinase (exon 20) domains associated with increased kinase activity strongly suggesting oncogenic potential </plain></SENT>
<SENT sid="2" pm="."><plain>Mutational analysis of previously unexamined <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> showed an amino acid change from threonine to alanine (T1025A) in exon 20 in one of 28 endometrial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> samples and 6 endometrial cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Additionally, a silent polymorphism (T1025T) was found in two of 20 MDS samples, one of 43 NHL samples, two of 40 <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> samples and Ishikawa </plain></SENT>
<SENT sid="4" pm="."><plain>The polymorphism was established by identifying two of 92 <z:mpath ids='MPATH_458'>normal</z:mpath> samples with the same change </plain></SENT>
<SENT sid="5" pm="."><plain>No PIK3CA mutations were found in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) as well as in <z:hpo ids='HP_0002669'>osteosarcomas</z:hpo>, prostate and <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> samples </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, a previously unidentified PIK3CA pseudogene spanning exons 9-13 on chromosome 22 was discovered </plain></SENT>
</text></document>